InvestorsHub Logo
Followers 46
Posts 6373
Boards Moderated 0
Alias Born 06/17/2009

Re: None

Tuesday, 10/17/2023 3:09:08 PM

Tuesday, October 17, 2023 3:09:08 PM

Post# of 470833
Gene therapy entry into Alzheimer's race.

Ultragenyx to spin off company to develop ‘high risk, high return’ gene therapy for Alzheimer’s disease


by Ayisha Sharma
News Reporter {for Endpoints}

https://endpts.com/ultragenyx-to-spin-off-company-to-develop-high-risk-high-return-gene-therapy-for-alzheimers-disease/
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News